What is Morgan Stanley's price target for ADCT?

Morgan Stanley's latest stated price target for ADC Therapeutics SA (ADCT) is $11, from its action on Sep 9, 2022.

What is Morgan Stanley's rating on ADCT?

Morgan Stanley rates ADCT Equal-Weight, a neutral rating, as of Sep 9, 2022.

When did Morgan Stanley last change its view on ADCT?

On Sep 9, 2022, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $17 to $11.

Morgan Stanley ADCT price target and rating history

ADC Therapeutics SA (ADCT) · Health Care

Morgan Stanley rates ADC Therapeutics SA (ADCT) Equal-Weight with a $11 price target, as of its latest action on Sep 9, 2022. It has published 4 rating actions on ADCT since July 2021, including 0 upgrades and 1 downgrade.

Current rating: Equal-Weight
Price target: $11
Median target, all firms: Too few
Actions on ADCT: 4

Morgan Stanley price target on ADCT

Morgan Stanley price target on ADCT, each point a stated target, July 2021 to September 2022.

Every Morgan Stanley rating on ADCT

Sep 9, 2022
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight, price target $17 to $11
Feb 1, 2022
ReiterateMorgan Stanley cuts its price target to $29 from $47, keeps Overweight
Sep 7, 2021
ReiterateMorgan Stanley cuts its price target to $47 from $51, keeps Overweight
Jul 16, 2021
ReiterateMorgan Stanley cuts its price target to $51 from $53, keeps Overweight

How other firms rate ADCT

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
H.C. Wainwright	Neutral		Jun 8, 2026
RBC Capital Markets	Sector Perform	$2	Jun 4, 2026

Questions about Morgan Stanley and ADCT

What is Morgan Stanley's price target for ADCT?: Morgan Stanley's latest stated price target for ADC Therapeutics SA (ADCT) is $11, from its action on Sep 9, 2022.
What is Morgan Stanley's rating on ADCT?: Morgan Stanley rates ADCT Equal-Weight, a neutral rating, as of Sep 9, 2022.
When did Morgan Stanley last change its view on ADCT?: On Sep 9, 2022, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $17 to $11.

More ADCT rating histories

RBC Capital Markets3

All Morgan Stanley ratings ADCT news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.